Dr. Lau is an academic detailing data manager, Department of Pharmacy, VHA Pharmacy Benefits Management, Los Angeles, California. Dr. Beste is a staff physician, Department of Medicine, Puget Sound VAMC and University of Washington School of Medicine, Seattle, Washington. Dr. Kryskalla is the VISN 22 pharmacoeconomist and pharmacy data analyst, Desert Pacific VISN in Long Beach, California. Dr. Rongey is the Viral Hepatitis National Public Health Clinical Lead, San Francisco VAMC, University of California San Francisco and an assistant professor at the University of California, San Francisco School of Medicine.
References
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
Disclaimer The opinions expressed herein are those of the authors and do not necessarily reflect those of Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.
